Efficacy and safety of glucagon-like peptide 1 agonists for Parkinson's disease: a systematic review and meta-analysis by Luis O. S. Nogueira, Roberto A. S. V. Mazetto, Maria L. R. Defante, Vânio L. J. Antunes, Ocílio Ribeiro Gonçalves, Angela Maria Sandini Corso, Marcus V. Della Coletta, Dayany Leonel Boone, Walderico Silva Machado Filho, Vanderci Borges, Henrique Ballalai Ferraz

Get full text

Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review by Vitor Tumas, Marcelo Jhonatan Aureliano, Carlos Roberto de Melo Rieder, Artur Francisco Schumacher Schuh, Henrique Ballalai Ferraz, Vanderci Borges, Maria Carolina Soares, Dayany Leonel Boone, Carolina Candeias da Silva, Mariana Cavalcanti Costa, Delson José da Silva, Aracelle Victor do Carmo, Luana de Rezende Mikael, Bruno Lopes Santos-Lobato, Ana Lucia Zuma Rosso, Celmir de Oliveira Vilaça, Pedro Braga-Neto, André Borges Ferreira Gomes, Camila Gonçalves Monteiro Carvalho, Grace Helena Letro, Denise Hack Nicaretta, Marcus Vinicius Della Coletta, Egberto Reis Barbosa, Rubens Gisbert Cury, Francisco Eduardo Costa Cardoso, Sarah Teixeira Camargos, Ignacio Fernandez Mata

Get full text